Additionally, although dose reduction, delay of treatment, and neutropenic fever were numerically higher in the mDCF arm in our study, they did not reach statistical significance.
← all excerpts
The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer.
1
—
—